Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Chronic Kidney Disease-Associated Anemia
Condition: Patient not on dialysis
Dose: Intravenous or Subcutaneous Injection – 50-100 units/kg
Frequency: three times weekly initially
Note: Initiate only when (1) hemoglobin level less than 10 g/dL, (2) rate of hemoglobin decline indicates likely necessity of red blood cell transfusion, and (3) reducing risk of alloimmunization or other risks related to red blood cell transfusion is goal; if hemoglobin level greater than 10 g/dL, reduce or interrupt dose and use lowest dose sufficient to reduce need for red blood cell transfusion
Indication: Chronic Kidney Disease-Associated Anemia
Condition: Patient on dialysis
Dose: Intravenous Injection – 50-100 units/kg
Frequency: three times weekly initially
Note: Initiate when hemoglobin level less than 10 g/dL; if hemoglobin level approaches or exceeds 11 g/dL, reduce or interrupt dose

Child Dose

Clinical InformationAdministration Information
Indication: Chronic Kidney Disease-Associated Anemia
Age: less than 1 month
Dose: Safety and efficacy not established
Note: Safety and efficacy not established
Indication: Chronic Kidney Disease-Associated Anemia
Age: greater than 1 month
Dose: Intravenous/Subcutaneous – 50 units/kg
Frequency: three times weekly initially
Note: if patient on dialysis, intravenous route recommended; Initiate when hemoglobin level less than 10 g/dL; if hemoglobin level approaches or exceeds 11 g/dL, reduce or interrupt dose
Administration
  • Must be administered under medical supervision
  • Follow prescribed schedule strictly
Side Effect

Drug Interaction

Drug NameRisk Factors
Haematinics (Iron preparations, Folic acid, Vitamin B12)
Enhance efficiency
Heparin
Increased dose in patients undergoing dialysis

Disease Interaction

Disease NameRisk Factors
No specific contraindications listed
Monitor for general drug reactions

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Erythropoietin should be stored at 2°C to 8°C. Protect from light. Do not freeze & avoid shaking.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.